IL2 and central nervous system cancer: In an autologous cytotoxicity assay, where peripheral blood mononuclear cells isolated from glioma patients were activated by IL-2 and co-incubated with the glioma cells from the same patient, treatment with AP 12009 restored their cytotoxic activity against glioma cells.